SQUAWK/NEWS
Menu
Live News EQUITY M impact

Immunic Names Lundgren CEO

Immunic appoints former Genentech executive Erik Lundgren as CEO, potentially impacting the company's strategy and direction. This move may have implications for the biotech industry.

IMUX

Immunic appoints former Genentech executive Erik Lundgren as CEO, potentially impacting the company's strategy and direction.

This move may have implications for the biotech industry.